173 related articles for article (PubMed ID: 20458577)
1. Validation of a case definition for osteoporosis disease surveillance.
Leslie WD; Lix LM; Yogendran MS
Osteoporos Int; 2011 Jan; 22(1):37-46. PubMed ID: 20458577
[TBL] [Abstract][Full Text] [Related]
2. Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases.
Lix LM; Yogendran MS; Leslie WD; Shaw SY; Baumgartner R; Bowman C; Metge C; Gumel A; Hux J; James RC
J Clin Epidemiol; 2008 Dec; 61(12):1250-1260. PubMed ID: 18619800
[TBL] [Abstract][Full Text] [Related]
3. Postfracture care for older women: gaps between optimal care and actual care.
Metge CJ; Leslie WD; Manness LJ; Yogendran M; Yuen CK; Kvern B;
Can Fam Physician; 2008 Sep; 54(9):1270-6. PubMed ID: 18791104
[TBL] [Abstract][Full Text] [Related]
4. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
[TBL] [Abstract][Full Text] [Related]
5. Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial.
Merle B; Chapurlat R; Vignot E; Thomas T; Haesebaert J; Schott AM
Osteoporos Int; 2017 May; 28(5):1549-1558. PubMed ID: 28246884
[TBL] [Abstract][Full Text] [Related]
6. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
7. Validity of self-reported osteoporosis in mid-age and older women.
Peeters GM; Tett SE; Dobson AJ; Mishra GD
Osteoporos Int; 2013 Mar; 24(3):917-27. PubMed ID: 22673826
[TBL] [Abstract][Full Text] [Related]
8. Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.
Asche C; Nelson R; McAdam-Marx C; Jhaveri M; Ye X
Osteoporos Int; 2010 Aug; 21(8):1427-36. PubMed ID: 19798459
[TBL] [Abstract][Full Text] [Related]
9. Sex difference in the validity of vertebral deformities as an index of prevalent vertebral osteoporotic fractures: a population survey of older men and women.
Leidig-Bruckner G; Limberg B; Felsenberg D; Bruckner T; Holder S; Kather A; Miksch J; Wüster C; Ziegler R; Scheidt-Nave C
Osteoporos Int; 2000; 11(2):102-19. PubMed ID: 10793868
[TBL] [Abstract][Full Text] [Related]
10. Initiation of osteoporosis treatment after bone mineral density testing.
Pressman A; Forsyth B; Ettinger B; Tosteson AN
Osteoporos Int; 2001; 12(5):337-42. PubMed ID: 11444079
[TBL] [Abstract][Full Text] [Related]
11. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting osteoporosis treatment initiation in a regionally based cohort.
Cranney A; Tsang JF; Leslie WD
Osteoporos Int; 2009 Sep; 20(9):1621-5. PubMed ID: 19096744
[TBL] [Abstract][Full Text] [Related]
13. Screening for osteoporosis using easily obtainable biometrical data: diagnostic accuracy of measured, self-reported and recalled BMI, and related costs of bone mineral density measurements.
van der Voort DJ; Brandon S; Dinant GJ; van Wersch JW
Osteoporos Int; 2000; 11(3):233-9. PubMed ID: 10824239
[TBL] [Abstract][Full Text] [Related]
14. A before-and-after study of fracture risk reporting and osteoporosis treatment initiation.
Leslie WD; Morin S; Lix LM
Ann Intern Med; 2010 Nov; 153(9):580-6. PubMed ID: 21041577
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis.
Huang S; Lin H; Zhu X; Chen X; Fan L; Liu C
Endokrynol Pol; 2014; 65(2):96-104. PubMed ID: 24802732
[TBL] [Abstract][Full Text] [Related]
16. Cancer patients with fractures are rarely assessed or treated for osteoporosis: a population-based study.
Leslie WD; Edwards B; Al-Azazi S; Yan L; Lix LM; Czaykowski P; Singh H
Osteoporos Int; 2021 Feb; 32(2):333-341. PubMed ID: 32808139
[TBL] [Abstract][Full Text] [Related]
17. Effect of raloxifene hydrochloride on bone mineral density and bone turnover in Kuwaiti postmenopausal women with osteoporosis.
Abdelazim IA; Abdelrazak KM; Al-Kadi M; Yehia AH; Nusair BM; Faza MA
Arch Osteoporos; 2014; 9():189. PubMed ID: 25037077
[TBL] [Abstract][Full Text] [Related]
18. Fracture prediction from repeat BMD measurements in clinical practice.
Leslie WD; Brennan-Olsen SL; Morin SN; Lix LM
Osteoporos Int; 2016 Jan; 27(1):203-10. PubMed ID: 26243362
[TBL] [Abstract][Full Text] [Related]
19. Ten-year prediction of osteoporosis from baseline bone mineral density: development of prognostic thresholds in healthy postmenopausal women. The Danish Osteoporosis Prevention Study.
Abrahamsen B; Rejnmark L; Nielsen SP; Rud B; Nissen N; Mosekilde L; Bärenholdt O; Jensen JE
Osteoporos Int; 2006 Feb; 17(2):245-51. PubMed ID: 16155732
[TBL] [Abstract][Full Text] [Related]
20. Validation of ten-year fracture risk prediction: a clinical cohort study from the Manitoba Bone Density Program.
Leslie WD; Tsang JF; Lix LM
Bone; 2008 Oct; 43(4):667-71. PubMed ID: 18602504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
